The Diagnosis-to-treatment Gap: A Biopharma Leadership Survey

As therapies become more dependent on testing and diagnosis, we're exploring how biopharma leaders are working to close the gap between identifying eligible patients and getting them on treatment. Take the survey and share your response. | As therapies become more dependent on testing and diagnosis, we're exploring how biopharma leaders are working to close the gap between identifying eligible patients and getting them on treatment. Take the survey and share your response.